Inoue balloon mitral valvotomy in patients with severe valvular and subvalvular deformity

University of Pennsylvania Medical Center, Philadelphia.

OBJECTIVES. This study evaluated the immediate and long-term results of percutaneous Inoue balloon mitral valvotomy in patients with severe valvular and subvalvular deformity. METHODS. We reviewed the prevalvotomy transthoracic echocardiograms of patients from the North American multicenter Inoue registry with total Massachusetts General Hospital (MGH) echocardiographic scores > or = 10. The echocardiograms were rescored by two investigators to assess valvular and subvalvular morphology to eliminate interinstitutional variability. Ninety patients were originally assigned scores > or = 10. After rescoring, 18 patients (20%) were eliminated, leaving 72 study patients. RESULTS. Balloon mitral valvotomy was technically successful in 69 (96%) of the 72 patients. Mean (+/- SD) mitral valve area increased from 0.9 +/- 0.3 to 1.5 +/- 0.5 cm2. An immediate optimal result, defined as > or = 50% increase in mitral valve area or a final area > or = 1.5 cm2 with no major complications, was achieved in 46 patients (64%). End points for clinical follow-up (events) included mitral valve replacement, repeat valvotomy or death. At a mean follow-up of 22.9 +/- 11.0 months, 22 patients (31%) required mitral valve replacement or a second valvotomy, 9 patients (13%) died, and 32 patients (45%) were in New York Heart Association functional class I or II. Univariate predictors of an immediate optimal result included sinus rhythm, male gender and a lower University of Southern California commissural calcium score. Only sinus rhythm predicted an optimal result by multivariate analysis. Actuarial 3-year event-free survival was 42%. Univariate predictors of event-free survival were a lower grade of mitral regurgitation, lower MGH total echocardiographic score, lower MGH leaflet thickness subscore and lower prevalvotomy left ventricular systolic pressure. Only grade of mitral regurgitation after valvotomy predicted event-free survival by multivariate analysis. CONCLUSIONS. Inoue mitral valvotomy in patients with severe valvular and subvalvular deformity has a high technical success rate and good immediate hemodynamic result but a high cardiovascular event rate in follow-up. Mitral valve replacement should be considered in surgical candidates with an MGH total echocardiographic score > or = 10 because it may be able to provide better long-term event-free survival. Balloon valvotomy remains a reasonable palliative therapeutic option for some patients with severe valvular deformity and high surgical risk.

This article has been cited by other articles:

				2006 WRITING COMMITTEE MEMBERS, R. O. Bonow, B. A. Carabello, K. Chatterjee, A. C. de Leon Jr, D. P. Faxon, M. D. Freed, W. H. Gaasch, B. W. Lytle, R. A. Nishimura, et al. 2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons Circulation, October 7, 2008; 118(15): e523 - e661. [Full Text] [PDF]

				R. O. Bonow, B. A. Carabello, K. Chatterjee, A. C. de Leon Jr, D. P. Faxon, M. D. Freed, W. H. Gaasch, B. W. Lytle, R. A. Nishimura, P. T. O'Gara, et al. 2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease) Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons J. Am. Coll. Cardiol., September 23, 2008; 52(13): e1 - e142. [Full Text] [PDF]

				R. O. Bonow, B. A. Carabello, K. Chatterjee, A. C. de Leon Jr, D. P. Faxon, M. D. Freed, W. H. Gaasch, B. W. Lytle, R. A. Nishimura, P. T. O'Gara, et al. ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease) Developed in Collaboration With the Society of Cardiovascular Anesthesiologists Endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons J. Am. Coll. Cardiol., August 1, 2006; 48(3): e1 - e148. [Full Text] [PDF]

				N Sutaria, T R D Shaw, B Prendergast, and D Northridge Transoesophageal echocardiographic assessment of mitral valve commissural morphology predicts outcome after balloon mitral valvotomy Heart, January 1, 2006; 92(1): 52 - 57. [Abstract] [Full Text] [PDF]

				T R D Shaw, N Sutaria, and B Prendergast Clinical and haemodynamic profiles of young, middle aged, and elderly patients with mitral stenosis undergoing mitral balloon valvotomy Heart, December 1, 2003; 89(12): 1430 - 1436. [Abstract] [Full Text] [PDF]

				Y. Turgeman, S. Atar, and T. Rosenfeld The Subvalvular Apparatus in Rheumatic Mitral Stenosis: Methods of Assessment and Therapeutic Implications Chest, November 1, 2003; 124(5): 1929 - 1936. [Abstract] [Full Text] [PDF]

				A. M. Abouzied, M. Al Abbady, M. F. Al Gendy, A. Magdy, H. Soliman, F. Faheem, T. Ramadan, and A. Yehia Percutaneous Balloon Mitral Commissurotomy During Pregnancy Angiology, March 1, 2001; 52(3): 205 - 209. [Abstract] [PDF]

				D.J.R Hildick-Smith, G.J Taylor, and L.M Shapiro Inoue balloon mitral valvuloplasty: long-term clinical and echocardiographic follow-up of a predominantly unfavourable population Eur. Heart J., October 2, 2000; 21(20): 1690 - 1697. [Abstract] [PDF]

				N Sutaria, D B Northridge, and T R D Shaw Significance of commissural calcification on outcome of mitral balloon valvotomy Heart, October 1, 2000; 84(4): 398 - 402. [Abstract] [Full Text]

				M. N. Leon, L. C. Harrell, H. F. Simosa, N. A. Mahdi, A. Pathan, J. Lopez-Cuellar, I. Inglessis, P. R. Moreno, and I. F. Palacios Mitral balloon valvotomy for patients with mitral stenosis in atrial fibrillation: Immediate and long-term results J. Am. Coll. Cardiol., October 1, 1999; 34(4): 1145 - 1152. [Abstract] [Full Text] [PDF]

				J. Langerveld, H.W. Thijs Plokker, S.M.P.G. Ernst, J.C. Kelder, and W. Jaarsma Predictors of clinical events or restenosis during follow-up after percutaneous mitral balloon valvotomy Eur. Heart J., April 1, 1999; 20(7): 519 - 526. [Abstract] [PDF]

				C. I. Stefanadis, C. G. Stratos, S. G. Lambrou, V. K. Bahl, D. V. Cokkinos, V. A. Voudris, S. G. Foussas, C. P. Tsioufis, and P. K. Toutouzas Retrograde nontransseptal balloon mitral valvuloplasty: immediate results and intermediate long-term outcome in 441 cases--a multicenter experience J. Am. Coll. Cardiol., October 1, 1998; 32(4): 1009 - 1016. [Abstract] [Full Text] [PDF]

				I. F. Palacios, P. L. Sanchez, L. C. Harrell, A. E. Weyman, and P. C. Block Which Patients Benefit From Percutaneous Mitral Balloon Valvuloplasty?: Prevalvuloplasty and Postvalvuloplasty Variables That Predict Long-Term Outcome Circulation, March 26, 2002; 105(12): 1465 - 1471. [Abstract] [Full Text] [PDF]